200 related articles for article (PubMed ID: 10764023)
1. Pathophysiology of the intrahepatic biliary epithelium.
Strazzabosco M; Spirlí C; Okolicsanyi L
J Gastroenterol Hepatol; 2000 Mar; 15(3):244-53. PubMed ID: 10764023
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of the intrahepatic biliary epithelium.
Glaser S; Francis H; Demorrow S; Lesage G; Fava G; Marzioni M; Venter J; Alpini G
World J Gastroenterol; 2006 Jun; 12(22):3523-36. PubMed ID: 16773709
[TBL] [Abstract][Full Text] [Related]
3. Pathophysiology of cholangiopathies.
Strazzabosco M; Fabris L; Spirli C
J Clin Gastroenterol; 2005 Apr; 39(4 Suppl 2):S90-S102. PubMed ID: 15758666
[TBL] [Abstract][Full Text] [Related]
4. Transport systems in cholangiocytes: their role in bile formation and cholestasis.
Strazzabosco M
Yale J Biol Med; 1997; 70(4):427-34. PubMed ID: 9626763
[TBL] [Abstract][Full Text] [Related]
5. Pathology and pathogenesis of intrahepatic bile duct loss.
Nakanuma Y; Tsuneyama K; Harada K
J Hepatobiliary Pancreat Surg; 2001; 8(4):303-15. PubMed ID: 11521175
[TBL] [Abstract][Full Text] [Related]
6. Cholangiocyte injury and ductopenic syndromes.
Xia X; Demorrow S; Francis H; Glaser S; Alpini G; Marzioni M; Fava G; Lesage G
Semin Liver Dis; 2007 Nov; 27(4):401-12. PubMed ID: 17979076
[TBL] [Abstract][Full Text] [Related]
7. The intrahepatic cholangiopathies.
Birnbaum A; Suchy FJ
Semin Liver Dis; 1998; 18(3):263-9. PubMed ID: 9773426
[TBL] [Abstract][Full Text] [Related]
8. If It Looks Like a Duct and Acts Like a Duct: On the Role of Reprogrammed Hepatocytes in Cholangiopathies.
Nejak-Bowen K
Gene Expr; 2020 Jun; 20(1):19-23. PubMed ID: 31439080
[TBL] [Abstract][Full Text] [Related]
9. Molecular and functional heterogeneity of cholangiocytes from rat liver after bile duct ligation.
Alpini G; Ulrich C; Roberts S; Phillips JO; Ueno Y; Podila PV; Colegio O; LeSage GD; Miller LJ; LaRusso NF
Am J Physiol; 1997 Feb; 272(2 Pt 1):G289-97. PubMed ID: 9124353
[TBL] [Abstract][Full Text] [Related]
10. Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases.
Trauner M; Fickert P; Halilbasic E; Moustafa T
Wien Med Wochenschr; 2008; 158(19-20):542-8. PubMed ID: 18998069
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical features of bile duct epithelial cells in normal and experimental liver conditions.
Onori P; Franchitto A; Alvaro D; Gaudio E
Ital J Anat Embryol; 2001; 106(2 Suppl 1):371-8. PubMed ID: 11729979
[TBL] [Abstract][Full Text] [Related]
12. Clinical implications of novel aspects of biliary pathophysiology.
Marzioni M; Saccomanno S; Candelaresi C; Rychlicki C; Agostinelli L; Trozzi L; De Minicis S; Benedetti A
Dig Liver Dis; 2010 Apr; 42(4):238-44. PubMed ID: 20167547
[TBL] [Abstract][Full Text] [Related]
13. Cholangiocyte pathobiology.
Banales JM; Huebert RC; Karlsen T; Strazzabosco M; LaRusso NF; Gores GJ
Nat Rev Gastroenterol Hepatol; 2019 May; 16(5):269-281. PubMed ID: 30850822
[TBL] [Abstract][Full Text] [Related]
14. The defects of cholangiocyte primary cilia in patients with graft cholangiopathies.
Lu HW; Dong JH; Li CH; Yu Q; Tang W
Clin Transplant; 2014 Oct; 28(10):1202-8. PubMed ID: 25319607
[TBL] [Abstract][Full Text] [Related]
15. Peptide antibiotic human beta-defensin-1 and -2 contribute to antimicrobial defense of the intrahepatic biliary tree.
Harada K; Ohba K; Ozaki S; Isse K; Hirayama T; Wada A; Nakanuma Y
Hepatology; 2004 Oct; 40(4):925-32. PubMed ID: 15382127
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide Y inhibits biliary hyperplasia of cholestatic rats by paracrine and autocrine mechanisms.
DeMorrow S; Meng F; Venter J; Leyva-Illades D; Francis H; Frampton G; Pae HY; Quinn M; Onori P; Glaser S; McDaniel K; Mancinelli R; Gaudio E; Alpini G; Franchitto A
Am J Physiol Gastrointest Liver Physiol; 2013 Aug; 305(3):G250-7. PubMed ID: 23703654
[TBL] [Abstract][Full Text] [Related]
17. Cholangiocyte death in ductopenic cholestatic cholangiopathies: Mechanistic basis and emerging therapeutic strategies.
Salas-Silva S; Simoni-Nieves A; Lopez-Ramirez J; Bucio L; Gómez-Quiroz LE; Gutiérrez-Ruiz MC; Roma MG
Life Sci; 2019 Feb; 218():324-339. PubMed ID: 30610870
[TBL] [Abstract][Full Text] [Related]
18. Site-characteristic expression and induction of trefoil factor family 1, 2 and 3 and malignant brain tumor-1 in normal and diseased intrahepatic bile ducts relates to biliary pathophysiology.
Sasaki M; Tsuneyama K; Saito T; Kataoka H; Mollenhauer J; Poustka A; Nakanuma Y
Liver Int; 2004 Feb; 24(1):29-37. PubMed ID: 15101998
[TBL] [Abstract][Full Text] [Related]
19. Human extrahepatic and intrahepatic cholangiocyte organoids show region-specific differentiation potential and model cystic fibrosis-related bile duct disease.
Verstegen MMA; Roos FJM; Burka K; Gehart H; Jager M; de Wolf M; Bijvelds MJC; de Jonge HR; Ardisasmita AI; van Huizen NA; Roest HP; de Jonge J; Koch M; Pampaloni F; Fuchs SA; Schene IF; Luider TM; van der Doef HPJ; Bodewes FAJA; de Kleine RHJ; Spee B; Kremers GJ; Clevers H; IJzermans JNM; Cuppen E; van der Laan LJW
Sci Rep; 2020 Dec; 10(1):21900. PubMed ID: 33318612
[TBL] [Abstract][Full Text] [Related]
20. Acute carbon tetrachloride feeding induces damage of large but not small cholangiocytes from BDL rat liver.
LeSage GD; Glaser SS; Marucci L; Benedetti A; Phinizy JL; Rodgers R; Caligiuri A; Papa E; Tretjak Z; Jezequel AM; Holcomb LA; Alpini G
Am J Physiol; 1999 May; 276(5):G1289-301. PubMed ID: 10330021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
